Legemiddelshopping av vanedannende medikamenter i Norge

Tidsskrift for den Norske Laegeforening

Volumn 129, Issue 6, 2009, Pages 517-520

  Winther, Rolf B ^a   Bramness, Jørgen G ^b  

^a Fylkesmannen i Buskerud   (Norway)

^b Nasjonalt folkehelseinstitutt ^*  (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; CARISOPRODOL; CENTRAL MUSCLE RELAXANT; CODEINE; DIAZEPAM; NARCOTIC ANALGESIC AGENT;

ADDICTION; ARTICLE; FEMALE; GENERAL PRACTICE; HUMAN; MALE; NORWAY; PRESCRIPTION; REGISTER; RISK FACTOR; STATISTICS;

ANALGESICS, OPIOID; ANTI-ANXIETY AGENTS; CARISOPRODOL; CODEINE; DIAZEPAM; DRUG PRESCRIPTIONS; FAMILY PRACTICE; FEMALE; HUMANS; MALE; MUSCLE RELAXANTS, CENTRAL; NORWAY; REGISTRIES; RISK FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 62449242092     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: 10.4045/tidsskr.09.34414     Document Type: Article

References (16)

1. Rønning M. Legemiddelforbruket i Norge 2002-2006. Oslo: Nasjonalt folkehelseinstitutt, 2007.
2. Waal H, Mørland J. Rusmiddelbruk og avhengighetstilstander. I: Trygve Fjeldstad, red. Norsk legemiddelhåndbok. Bergen: Fagbokforlaget, 2007. www.legemiddelhandboka.no/xml/(13.4.2008).
3. Oliver P, Keen J, Rowse G et al. Deaths from drugs of abuse in Sheffield, 1998: the role of prescribed medication. Br J Gen Pract 2001; 51: 394-6.
4. Martyres RF, Clode D, Burns JM. Seeking drugs or seeking help? Escalating «doctor shopping» by young heroin users before fatal overdose. Med J Aust 2004; 180: 211-4.
5. Smith-Solbakken M, Lie T. Piller på avveie. RF-1999/097. Stavanger: Rogalandsforskning, 1999.
6. Klienschmidt R, Price J, Caught K. Doctor shopping. Aust Fam Physician 1995; 24: 1037-41.
7. Pradel V, Thirion X, Ronfle E et al. Assessment of doctor-shopping for high dosage buprenorphine maintenance treatment in a French region: development of a new method for prescription database. Pharmacoepidemiol Drug Safe 2004; 13: 473-81.
8. St.meld. nr. 23 (1996-97). Trygghet og ansvarlighet. Om legetjenesten i kommunene og fastlegeordningen. Oslo: Sosial- og helsedepartementet, 1997.
9. Ot.prp. nr. 99 (1998-99). Om lov om endringer i lov av 19. november 1982 nr. 66 om helsetjenesten i kommunene og i visse andre lover (fastlegeordningen). Oslo: Sosial- og helsedepartementet, 1999.
10. Styringsdata for fastlegeordningen, 3. kvartal 2007. Oslo: Arbeids- og velferdsdirektoratet, oktober 2007. www.nav.no/binary/805364343/file (13.4.2008).
11. Furu K, Strøm H, Rønning M et al. The Norwegian Prescription Database (NorPD): new register for pharmacoepidemiological research covering a whole nation. Pharmacoepidemiol Drug Safe 2005; 14: S48.
12. Hallas J, Støvring H. Templates for analysis of individual-level prescription data. Basic Clin Pharmacol Toxicol 2006; 98: 260-5.
13. Kamien M. «Doctor shoppers»: at risk by any other name. Med J Aust 2004; 180: 204-5.
14. Darke S, Ross J, Teesson M et al. Health service utilization and benzodiazepine use among young heroin users: findings from the Australian Treatment Outcome Study (ATOS). Addiction 2003; 98: 1129-35.
15. Burns JM, Martyres RF, Clode D et al. Overdose in young people using heroin: associations with mental health, prescription drug use and personal circumstances. Med J Aust 2004; 181 (7 suppl): 25-8.
16. Bramness JG, Furu K, Engeland A et al. Carisoprodol use and abuse in Norway: a pharmacoepidemiological study. Br J Clin Pharmacol 2007; 64: 210-8.